2009 - Review: Pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality

Johnstone, Jennie
May 2009
ACP Journal Club;5/19/2009, Vol. 150 Issue 5, p2
Academic Journal
The article cites several studies to find out whether pneumococcal vaccination is effective for various clinical outcomes in adults. The studies compared pneumococcal polysaccharide vaccine with placebo, other vaccines, or no intervention control. Meta-analysis of the studies showed that pneumococcal vaccination did not differ from control for definitive pneumococcal pneumonia and that the pneumococcal vaccination group had fewer cases of presumptive pneumococcal pneumonia.


Related Articles

  • Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. Maruyama, Takaya; Taguchi, Osamu; Niederman, Michael S.; Morser, John; Kobayashi, Hiroyasu; Kobayashi, Tetsu; D'Alessandro-Gabazza, Corina; Nakayama, Sei; Nishikubo, Kimiaki; Noguchi, Takashi; Takei, Yoshiyuki; Gabazza, Esteban C. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/13/2010, Vol. 340 Issue 7746, p579 

    The article discusses a double blind, randomised and placebo controlled trial, which investigated the efficacy of the 3-valent pneumococcal polysaccharide vaccine in preventing pneumonia and improving survival in nursing home residents in Japan. The trial involved 1,006 nursing home residents in...

  • Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine Administered According to 4 Different Primary Immunization Schedules in Infants. Spijkerman, Judith; Veenhoven, Reinier H.; Wijmenga-Monsuur, Alienke J.; Elberse, Karin E. M.; van Gageldonk, Pieter G. M.; Knol, Miriam J.; de Melker, Hester E.; Sanders, Elisabeth A. M.; Schouls, Leo M.; Berbers, Guy A. M. // JAMA: Journal of the American Medical Association;9/4/2013, Vol. 310 Issue 9, p930 

    IMPORTANCE Immunization schedules with pneumococcal conjugate vaccine (PCV) differ among countries regarding the number of doses, age at vaccinations, and interval between doses. OBJECTIVE To assess the optimal primary vaccination schedule by comparing immunogenicity of 13-valent PCV (PCV13) in...

  • Does treatment with donepezil improve memory for patients with mild cognitive impairment? Stiles, Melissa M.; Martin, Sandra // Journal of Family Practice;May2006, Vol. 55 Issue 5, p435 

    The article presents information on the studies conducted to determine if treatment for patients with mild cognitive impairment with Donepezil can improve the patients' memories. Donepezil does not improve the patients' memory with the impairment is an evidence based answer, and its cost, the...

  • THE PLACEBO: A READER. Lott, Rob // Health Affairs;Mar2014, Vol. 33 Issue 3, p518 

    No abstract available.

  • Ethics of the use of placebos in clinical research: a proposal for decision-making algorithms. Guerreiro Fregnani, José Humberto Tavares; Carvalho, André Lopes; Paranhos, Flávio Rocha Lima; de Souza Viana, Luciano; Serrano, Sérgio Vicente; Cárcano, Flávio; Ferreira, João Fernando Monteiro; Zier, Sandra Solci; Gontijo, Pollyana Anício Magalhães; Stefanoff, Cláudio Gustavo; França, Paulo Henrique Condeixa; de Almeida Bendati, Maria Mercedes; Marodin, Gabriela; de Almeida Venâncio, Jorge Alves // Revista Bioetica;2015, Vol. 23 Issue 3, p456 

    The use of placebos in clinical research has been a matter of considerable debate in recent years, notably when the World Medical Association published, in 2002, a note of clarification for paragraph 29 of the Helsinki Declaration. Brazil is known for its strong opposition to the flexible use of...

  • Antigens from Leishmania amastigotes induced clinical remission of psoriasis. O'Daly, J. A.; Lezama, R.; Rodriguez, P. J.; Silva, E.; Indriago, N. R.; Peña, G.; Colorado, I.; Gleason, J.; Rodríguez, B.; Acuña, L.; Ovalles, T. // Archives of Dermatological Research;Jan2009, Vol. 301 Issue 1, p1 

    While injecting volunteers in Venezuela with a vaccine for prevention of leishmaniasis, we observed 100% clinical remission of a psoriatic lesion in one subject. Subsequently, the vaccine (AS100) was evaluated in psoriatic patients with an open label, single center study. The study was conducted...

  • Rotavirus Serotype G9 Is Associated with More-Severe Disease in Latin America. Linhares, A. C.; Verstraeten, Thomas; Wolleswinkel-van den Bosch, Judith; Clemens, Ralf; Breuer, Thomas // Clinical Infectious Diseases;8/1/2006, Vol. 43 Issue 3, p312 

    The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to...

  • Reduction of Carriage and Transmission of reptococcus pneumoniae: The Beneficial "Side Effect" of Pneumococcal Conjugate Vaccine. Azzari, Chiara; Resti, Massimo // Clinical Infectious Diseases;10/15/2008, Vol. 47 Issue 8, p997 

    The article focuses on the indirect effects of the 7-valent polysaccharide pneumococcal conjugate vaccine (PCV7) on the reduction of carriage and transmission of streptococcus pneumoniae. Continuing observation of pneumococcal carriage and invasive pneumococcal disease (IPD) has been suggested...

  • "Sizeable" societal savings from two-dose PCV13 schedule.  // PharmacoEconomics & Outcomes News;7/6/2013, Issue 683, p4 

    The article discusses research on the cost savings associated with removing the third, 6-month dose of the 13-valent pneumococcal conjugate vaccine (PCV13) primary dose series, referencing a study by C. Stoecker and colleagues published in the July 2013 issue of "Pediatrics."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics